From Knowing to Controlling: A Path from Genomics to Drugs Using Small Molecule Probes
Open Access
- 11 April 2003
- journal article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 300 (5617) , 294-295
- https://doi.org/10.1126/science.1083395
Abstract
The National Cancer Institute Initiative in Chemical Genetics is designed to encourage the development of small molecular probes. The probes are useful for activating or inactivating protein functions, thereby providing resources that help discern the functions of gene products in normal and disease cells, as well as in tissues. This initiative includes “ChemBank,” a suite of informatics tools and databases aimed at promoting the development and use of chemical genetics by scientists worldwide. The information generated with such tools should provide a critical link from genomic discovery to drug development.Keywords
This publication has 9 references indexed in Scilit:
- Dissecting Temporal and Spatial Control of Cytokinesis with a Myosin II InhibitorScience, 2003
- PERSPECTIVEPublished by American Chemical Society (ACS) ,2003
- RNAi: gene-silencing in therapeutic interventionDrug Discovery Today, 2002
- Cancer Modeling in the Modern EraCell, 2002
- A one-bead, one-stock solution approach to chemical genetics: part 1Chemistry & Biology, 2001
- A one-bead, one-stock solution approach to chemical genetics: part 2Chemistry & Biology, 2001
- Genome and genetic resources from the Cancer Genome Anatomy ProjectHuman Molecular Genetics, 2001
- Target-Oriented and Diversity-Oriented Organic Synthesis in Drug DiscoveryScience, 2000
- Small Molecule Inhibitor of Mitotic Spindle Bipolarity Identified in a Phenotype-Based ScreenScience, 1999